P & G Health Ltd

  • Market Cap: Small Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: INE199A01012
  • NSEID: PGHL
  • BSEID: 500126
INR
6,214.00
-34 (-0.54%)
BSENSE

Jun 25, 03:04 PM

BSE+NSE Vol: 6.17 k

  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationNine Monthly Results
Results Snapshot
Figures in Cr
Standalone Nine Monthly Results
Dec'25
Dec'24
Dec'23
Dec'22
Dec'21
Dec'20
Dec'19
Nine Monthly Analysis Highlights
stock-summary

Net Sales

YoY Growth in nine months ended Dec 2025 is 14.38% vs 4.57% in Dec 2024

stock-summary

Standalone Net Profit

YoY Growth in nine months ended Dec 2025 is 22.26% vs 3.15% in Dec 2024

stock-summary

Operating Profit (PBDIT) excl Other Income

YoY Growth in nine months ended Dec 2025 is 12.37% vs 10.85% in Dec 2024

stock-summary

Interest

YoY Growth in nine months ended Dec 2025 is -32.00% vs -3.85% in Dec 2024

stock-summary

Operating Profit Margin (Excl OI)

YoY Growth in nine months ended Dec 2025 has fallen from Dec 2024

Compare Nine Monthly Results Of P & G Health Ltd With
Markets Mojo
Figures in Cr
Standalone Nine Monthly Results
Markets Mojo
Markets Mojo
Change(INR)
Change(%)
Net Sales
1,037.52
627.40
410.12
65.37%
Other Operating Income
0.00
0.00
0.00
Total Operating income
1,037.52
627.40
410.12
65.37%
Raw Material Cost
222.14
110.80
111.34
100.49%
Purchase of Finished goods
48.27
64.10
-15.83
-24.70%
(Increase) / Decrease In Stocks
1.80
-13.10
14.90
113.74%
Employee Cost
171.70
93.30
78.40
84.03%
Power Cost
0.00
0.00
0.00
Manufacturing Expenses
0.00
0.00
0.00
Selling and Distribution Expenses
0.00
0.00
0.00
Other Expenses
272.54
153.10
119.44
78.01%
Total Expenditure (Excl Depreciation)
716.45
408.20
308.25
75.51%
Operating Profit (PBDIT) excl Other Income
321.07
219.20
101.87
46.47%
Other Income
13.34
13.80
-0.46
-3.33%
Operating Profit (PBDIT)
334.41
233.00
101.41
43.52%
Interest
0.34
1.50
-1.16
-77.33%
Exceptional Items
0.00
6.60
-6.60
-100.00%
Gross Profit (PBDT)
334.07
238.10
95.97
40.31%
Depreciation
17.42
8.30
9.12
109.88%
Profit Before Tax
316.65
229.80
86.85
37.79%
Tax
84.34
56.20
28.14
50.07%
Provisions and contingencies
0.00
0.00
0.00
Profit After Tax
232.31
173.60
58.71
33.82%
Extraordinary Items
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
Net Profit
232.31
173.60
58.71
33.82%
Equity Capital
16.60
23.00
-6.40
-27.83%
Face Value
10.00
10.00
0.00
Reserves
0.00
0.00
0.00
Earnings per share (EPS)
0.00
0.00
0.00
Operating Profit Margin (Excl OI)
30.95%
34.94%
0.00
-3.99%
Gross Profit Margin
32.20%
37.95%
0.00
-5.75%
Public Share Holdings (%)
0.00%
0.00%
0.00
0.00%
Nine Monthly - Net Sales
Net Sales 1,037.52 Cr
in Dec 2025

Figures in Cr
stock-summary

YoY Growth in nine months ended Dec 2025 is 14.38% vs 4.57% in Dec 2024

Nine Monthly - Standalone Net Profit
Standalone Net Profit 232.31 Cr
in Dec 2025

Figures in Cr
stock-summary

YoY Growth in nine months ended Dec 2025 is 22.26% vs 3.15% in Dec 2024

Nine Monthly - Operating Profit (PBDIT)
Operating Profit (PBDIT) 321.07 Cr
in Dec 2025

Figures in Cr
stock-summary

YoY Growth in nine months ended Dec 2025 is 12.37% vs 10.85% in Dec 2024

Nine Monthly - Interest
Interest 0.34 Cr
in Dec 2025

Figures in Cr
stock-summary

YoY Growth in nine months ended Dec 2025 is -32.00% vs -3.85% in Dec 2024

Nine Monthly - Operating Profit Margin (Excl OI)
Operating Profit Margin (Excl OI) 30.95%
in Dec 2025

Figures in %
stock-summary

YoY Growth in nine months ended Dec 2025 has fallen from Dec 2024